CLINICAL_TRIALS
trial_result
· 2020-03-05
Clinical Trial Update: Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia [Phase 4]
Summary
Phase 4 trial update for standard risk acute lymphoblastic leukemia treated under the Pethema LAL-RI/2008 study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PETHEMA Foundation | Conditions: Acute Lymphobkastic Leukemia | Phase 4 | Status: COMPLETED